Lindbrook Capital, LLC - TCR2 THERAPEUTICS INC ownership

TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 122 filers reported holding TCR2 THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 2.23 and the average weighting 0.1%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of TCR2 THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$4,575
+50.2%
3,0500.0%0.00%
Q4 2022$3,046
-39.1%
3,0500.0%0.00%
-100.0%
Q3 2022$5,000
-44.4%
3,0500.0%0.00%0.0%
Q2 2022$9,000
+12.5%
3,0500.0%0.00%0.0%
Q1 2022$8,000
-42.9%
3,0500.0%0.00%
-50.0%
Q4 2021$14,0003,0500.00%
Other shareholders
TCR2 THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,050,865$4,046,8141.69%
MPM BioImpact LLC 3,370,982$3,367,6110.87%
TANG CAPITAL MANAGEMENT LLC 2,738,947$2,735,6600.40%
Newtyn Management, LLC 1,075,000$1,073,7100.22%
HARBOR CAPITAL ADVISORS, INC. 68,230$68,1480.07%
Artal Group S.A. 750,000$7490.04%
Oasis Management Co Ltd. 200,000$199,7600.04%
Redmile Group, LLC 731,379$730,5010.03%
X-Square Capital, LLC 31,919$320.02%
CORNERCAP INVESTMENT COUNSEL INC 68,035$67,9530.01%
View complete list of TCR2 THERAPEUTICS INC shareholders